aFGF Targeted Mediated by Novel Nanoparticles-Microbubble Complex Combined With Ultrasound-Targeted Microbubble Destruction attenuates Doxorubicin-Induced Heart Failure via Anti-Apoptosis and Promoting Cardiac Angiogenesis
The purpose of this study was to evaluate the protective effect of acidic fibroblast growth factor targeted mediated by novel nanoparticles–cationic lipid microbubbles complex (aFGF–NP + CPMBs) combined with ultrasound targeted microbubble destruction (UTMD)on doxorubicin–induced heart failure (HF)a...
Main Authors: | , , , , , , , , , , , |
---|---|
Format: | Article |
Language: | English |
Published: |
Frontiers Media S.A.
2021-04-01
|
Series: | Frontiers in Pharmacology |
Subjects: | |
Online Access: | https://www.frontiersin.org/articles/10.3389/fphar.2021.607785/full |
id |
doaj-bdbf18cbdf9c456590c304edb1d5cc8f |
---|---|
record_format |
Article |
collection |
DOAJ |
language |
English |
format |
Article |
sources |
DOAJ |
author |
Nan-Qian Zhou Nan-Qian Zhou Nan-Qian Zhou Zhi-Xin Fang Zhi-Xin Fang Zhi-Xin Fang Ning Huang Ning Huang Ning Huang Yue Zuo Yue Qiu Yue Qiu Yue Qiu Li-Juan Guo Ping Song Ping Song Ping Song Jian Xu Jian Xu Jian Xu Guang-rui Wan Guang-rui Wan Guang-rui Wan Xin-Qiao Tian Ya-ling Yin Peng Li Peng Li Peng Li |
spellingShingle |
Nan-Qian Zhou Nan-Qian Zhou Nan-Qian Zhou Zhi-Xin Fang Zhi-Xin Fang Zhi-Xin Fang Ning Huang Ning Huang Ning Huang Yue Zuo Yue Qiu Yue Qiu Yue Qiu Li-Juan Guo Ping Song Ping Song Ping Song Jian Xu Jian Xu Jian Xu Guang-rui Wan Guang-rui Wan Guang-rui Wan Xin-Qiao Tian Ya-ling Yin Peng Li Peng Li Peng Li aFGF Targeted Mediated by Novel Nanoparticles-Microbubble Complex Combined With Ultrasound-Targeted Microbubble Destruction attenuates Doxorubicin-Induced Heart Failure via Anti-Apoptosis and Promoting Cardiac Angiogenesis Frontiers in Pharmacology doxorubicin heart failure aFGF-NP anti-apoptotic angiogenesis UTMD |
author_facet |
Nan-Qian Zhou Nan-Qian Zhou Nan-Qian Zhou Zhi-Xin Fang Zhi-Xin Fang Zhi-Xin Fang Ning Huang Ning Huang Ning Huang Yue Zuo Yue Qiu Yue Qiu Yue Qiu Li-Juan Guo Ping Song Ping Song Ping Song Jian Xu Jian Xu Jian Xu Guang-rui Wan Guang-rui Wan Guang-rui Wan Xin-Qiao Tian Ya-ling Yin Peng Li Peng Li Peng Li |
author_sort |
Nan-Qian Zhou |
title |
aFGF Targeted Mediated by Novel Nanoparticles-Microbubble Complex Combined With Ultrasound-Targeted Microbubble Destruction attenuates Doxorubicin-Induced Heart Failure via Anti-Apoptosis and Promoting Cardiac Angiogenesis |
title_short |
aFGF Targeted Mediated by Novel Nanoparticles-Microbubble Complex Combined With Ultrasound-Targeted Microbubble Destruction attenuates Doxorubicin-Induced Heart Failure via Anti-Apoptosis and Promoting Cardiac Angiogenesis |
title_full |
aFGF Targeted Mediated by Novel Nanoparticles-Microbubble Complex Combined With Ultrasound-Targeted Microbubble Destruction attenuates Doxorubicin-Induced Heart Failure via Anti-Apoptosis and Promoting Cardiac Angiogenesis |
title_fullStr |
aFGF Targeted Mediated by Novel Nanoparticles-Microbubble Complex Combined With Ultrasound-Targeted Microbubble Destruction attenuates Doxorubicin-Induced Heart Failure via Anti-Apoptosis and Promoting Cardiac Angiogenesis |
title_full_unstemmed |
aFGF Targeted Mediated by Novel Nanoparticles-Microbubble Complex Combined With Ultrasound-Targeted Microbubble Destruction attenuates Doxorubicin-Induced Heart Failure via Anti-Apoptosis and Promoting Cardiac Angiogenesis |
title_sort |
afgf targeted mediated by novel nanoparticles-microbubble complex combined with ultrasound-targeted microbubble destruction attenuates doxorubicin-induced heart failure via anti-apoptosis and promoting cardiac angiogenesis |
publisher |
Frontiers Media S.A. |
series |
Frontiers in Pharmacology |
issn |
1663-9812 |
publishDate |
2021-04-01 |
description |
The purpose of this study was to evaluate the protective effect of acidic fibroblast growth factor targeted mediated by novel nanoparticles–cationic lipid microbubbles complex (aFGF–NP + CPMBs) combined with ultrasound targeted microbubble destruction (UTMD)on doxorubicin–induced heart failure (HF)and its mechanism. Heart failure rats induced by intraperitoneal injection with doxorubicin (DOX) to achieve cummulative dose of 15mg/kg for continuous 6 weeks showed left ventricular dysfunction, seriously oxidative stress, cardiomyocyte apoptosis, and decrease of myocardial vascular density. In contrast, aFGF–NP + CPMBs combined with UTMD therapy (3ug/kg, caudal vein injection, twice a week, 6weeks)prominently ameliorated left ventricular dysfunction by increased ejection fraction (EF) and fractional shortening (FS), decreased brain natriuretic peptide (BNP); strengthened the ability of antioxidant stress confirmed by increasing the activity of SOD and reducing the production of MDA; exerted the effect of anti–cardiomyocyte apoptosis and promotion angiogenesis by inhibited Bax expression and increased Bcl–2 expression and platelet endothelial cell adhesion molecule (CD31) expression. Taken together, the research suggested that aFGF targeted mediated by novel nanoparticles–cationic lipid microbubbles complex combined with UTMD should be a promising targeted treatment for heart failure. |
topic |
doxorubicin heart failure aFGF-NP anti-apoptotic angiogenesis UTMD |
url |
https://www.frontiersin.org/articles/10.3389/fphar.2021.607785/full |
work_keys_str_mv |
AT nanqianzhou afgftargetedmediatedbynovelnanoparticlesmicrobubblecomplexcombinedwithultrasoundtargetedmicrobubbledestructionattenuatesdoxorubicininducedheartfailureviaantiapoptosisandpromotingcardiacangiogenesis AT nanqianzhou afgftargetedmediatedbynovelnanoparticlesmicrobubblecomplexcombinedwithultrasoundtargetedmicrobubbledestructionattenuatesdoxorubicininducedheartfailureviaantiapoptosisandpromotingcardiacangiogenesis AT nanqianzhou afgftargetedmediatedbynovelnanoparticlesmicrobubblecomplexcombinedwithultrasoundtargetedmicrobubbledestructionattenuatesdoxorubicininducedheartfailureviaantiapoptosisandpromotingcardiacangiogenesis AT zhixinfang afgftargetedmediatedbynovelnanoparticlesmicrobubblecomplexcombinedwithultrasoundtargetedmicrobubbledestructionattenuatesdoxorubicininducedheartfailureviaantiapoptosisandpromotingcardiacangiogenesis AT zhixinfang afgftargetedmediatedbynovelnanoparticlesmicrobubblecomplexcombinedwithultrasoundtargetedmicrobubbledestructionattenuatesdoxorubicininducedheartfailureviaantiapoptosisandpromotingcardiacangiogenesis AT zhixinfang afgftargetedmediatedbynovelnanoparticlesmicrobubblecomplexcombinedwithultrasoundtargetedmicrobubbledestructionattenuatesdoxorubicininducedheartfailureviaantiapoptosisandpromotingcardiacangiogenesis AT ninghuang afgftargetedmediatedbynovelnanoparticlesmicrobubblecomplexcombinedwithultrasoundtargetedmicrobubbledestructionattenuatesdoxorubicininducedheartfailureviaantiapoptosisandpromotingcardiacangiogenesis AT ninghuang afgftargetedmediatedbynovelnanoparticlesmicrobubblecomplexcombinedwithultrasoundtargetedmicrobubbledestructionattenuatesdoxorubicininducedheartfailureviaantiapoptosisandpromotingcardiacangiogenesis AT ninghuang afgftargetedmediatedbynovelnanoparticlesmicrobubblecomplexcombinedwithultrasoundtargetedmicrobubbledestructionattenuatesdoxorubicininducedheartfailureviaantiapoptosisandpromotingcardiacangiogenesis AT yuezuo afgftargetedmediatedbynovelnanoparticlesmicrobubblecomplexcombinedwithultrasoundtargetedmicrobubbledestructionattenuatesdoxorubicininducedheartfailureviaantiapoptosisandpromotingcardiacangiogenesis AT yueqiu afgftargetedmediatedbynovelnanoparticlesmicrobubblecomplexcombinedwithultrasoundtargetedmicrobubbledestructionattenuatesdoxorubicininducedheartfailureviaantiapoptosisandpromotingcardiacangiogenesis AT yueqiu afgftargetedmediatedbynovelnanoparticlesmicrobubblecomplexcombinedwithultrasoundtargetedmicrobubbledestructionattenuatesdoxorubicininducedheartfailureviaantiapoptosisandpromotingcardiacangiogenesis AT yueqiu afgftargetedmediatedbynovelnanoparticlesmicrobubblecomplexcombinedwithultrasoundtargetedmicrobubbledestructionattenuatesdoxorubicininducedheartfailureviaantiapoptosisandpromotingcardiacangiogenesis AT lijuanguo afgftargetedmediatedbynovelnanoparticlesmicrobubblecomplexcombinedwithultrasoundtargetedmicrobubbledestructionattenuatesdoxorubicininducedheartfailureviaantiapoptosisandpromotingcardiacangiogenesis AT pingsong afgftargetedmediatedbynovelnanoparticlesmicrobubblecomplexcombinedwithultrasoundtargetedmicrobubbledestructionattenuatesdoxorubicininducedheartfailureviaantiapoptosisandpromotingcardiacangiogenesis AT pingsong afgftargetedmediatedbynovelnanoparticlesmicrobubblecomplexcombinedwithultrasoundtargetedmicrobubbledestructionattenuatesdoxorubicininducedheartfailureviaantiapoptosisandpromotingcardiacangiogenesis AT pingsong afgftargetedmediatedbynovelnanoparticlesmicrobubblecomplexcombinedwithultrasoundtargetedmicrobubbledestructionattenuatesdoxorubicininducedheartfailureviaantiapoptosisandpromotingcardiacangiogenesis AT jianxu afgftargetedmediatedbynovelnanoparticlesmicrobubblecomplexcombinedwithultrasoundtargetedmicrobubbledestructionattenuatesdoxorubicininducedheartfailureviaantiapoptosisandpromotingcardiacangiogenesis AT jianxu afgftargetedmediatedbynovelnanoparticlesmicrobubblecomplexcombinedwithultrasoundtargetedmicrobubbledestructionattenuatesdoxorubicininducedheartfailureviaantiapoptosisandpromotingcardiacangiogenesis AT jianxu afgftargetedmediatedbynovelnanoparticlesmicrobubblecomplexcombinedwithultrasoundtargetedmicrobubbledestructionattenuatesdoxorubicininducedheartfailureviaantiapoptosisandpromotingcardiacangiogenesis AT guangruiwan afgftargetedmediatedbynovelnanoparticlesmicrobubblecomplexcombinedwithultrasoundtargetedmicrobubbledestructionattenuatesdoxorubicininducedheartfailureviaantiapoptosisandpromotingcardiacangiogenesis AT guangruiwan afgftargetedmediatedbynovelnanoparticlesmicrobubblecomplexcombinedwithultrasoundtargetedmicrobubbledestructionattenuatesdoxorubicininducedheartfailureviaantiapoptosisandpromotingcardiacangiogenesis AT guangruiwan afgftargetedmediatedbynovelnanoparticlesmicrobubblecomplexcombinedwithultrasoundtargetedmicrobubbledestructionattenuatesdoxorubicininducedheartfailureviaantiapoptosisandpromotingcardiacangiogenesis AT xinqiaotian afgftargetedmediatedbynovelnanoparticlesmicrobubblecomplexcombinedwithultrasoundtargetedmicrobubbledestructionattenuatesdoxorubicininducedheartfailureviaantiapoptosisandpromotingcardiacangiogenesis AT yalingyin afgftargetedmediatedbynovelnanoparticlesmicrobubblecomplexcombinedwithultrasoundtargetedmicrobubbledestructionattenuatesdoxorubicininducedheartfailureviaantiapoptosisandpromotingcardiacangiogenesis AT pengli afgftargetedmediatedbynovelnanoparticlesmicrobubblecomplexcombinedwithultrasoundtargetedmicrobubbledestructionattenuatesdoxorubicininducedheartfailureviaantiapoptosisandpromotingcardiacangiogenesis AT pengli afgftargetedmediatedbynovelnanoparticlesmicrobubblecomplexcombinedwithultrasoundtargetedmicrobubbledestructionattenuatesdoxorubicininducedheartfailureviaantiapoptosisandpromotingcardiacangiogenesis AT pengli afgftargetedmediatedbynovelnanoparticlesmicrobubblecomplexcombinedwithultrasoundtargetedmicrobubbledestructionattenuatesdoxorubicininducedheartfailureviaantiapoptosisandpromotingcardiacangiogenesis |
_version_ |
1721506277366956032 |
spelling |
doaj-bdbf18cbdf9c456590c304edb1d5cc8f2021-04-27T06:16:48ZengFrontiers Media S.A.Frontiers in Pharmacology1663-98122021-04-011210.3389/fphar.2021.607785607785aFGF Targeted Mediated by Novel Nanoparticles-Microbubble Complex Combined With Ultrasound-Targeted Microbubble Destruction attenuates Doxorubicin-Induced Heart Failure via Anti-Apoptosis and Promoting Cardiac AngiogenesisNan-Qian Zhou0Nan-Qian Zhou1Nan-Qian Zhou2Zhi-Xin Fang3Zhi-Xin Fang4Zhi-Xin Fang5Ning Huang6Ning Huang7Ning Huang8Yue Zuo9Yue Qiu10Yue Qiu11Yue Qiu12Li-Juan Guo13Ping Song14Ping Song15Ping Song16Jian Xu17Jian Xu18Jian Xu19Guang-rui Wan20Guang-rui Wan21Guang-rui Wan22Xin-Qiao Tian23Ya-ling Yin24Peng Li25Peng Li26Peng Li27Department of Ultrasonography, Henan Provincial People’s Hospital, People’s Hospital of Zhengzhou University, Zhengzhou, ChinaHenan International Joint Laboratory of Cardiovascular Remodeling and Drug Intervention, Xinxiang, China.Xinxiang Key Laboratory of Vascular Remodeling Intervention and Molecular Targeted Therapy Drug Development, Xinxiang, ChinaHenan International Joint Laboratory of Cardiovascular Remodeling and Drug Intervention, Xinxiang, China.Xinxiang Key Laboratory of Vascular Remodeling Intervention and Molecular Targeted Therapy Drug Development, Xinxiang, ChinaCollege of Pharmacy, Xinxiang Medical University, Xinxiang, ChinaHenan International Joint Laboratory of Cardiovascular Remodeling and Drug Intervention, Xinxiang, China.Xinxiang Key Laboratory of Vascular Remodeling Intervention and Molecular Targeted Therapy Drug Development, Xinxiang, ChinaCollege of Pharmacy, Xinxiang Medical University, Xinxiang, ChinaSchool of Basic Medical Sciences, Xinxiang Medical University, Xinxiang, ChinaHenan International Joint Laboratory of Cardiovascular Remodeling and Drug Intervention, Xinxiang, China.Xinxiang Key Laboratory of Vascular Remodeling Intervention and Molecular Targeted Therapy Drug Development, Xinxiang, ChinaCollege of Pharmacy, Xinxiang Medical University, Xinxiang, ChinaDepartment of Oncology, First Affiliated Hospital of Xinxiang Medical University, Xinxiang, ChinaHenan International Joint Laboratory of Cardiovascular Remodeling and Drug Intervention, Xinxiang, China.Xinxiang Key Laboratory of Vascular Remodeling Intervention and Molecular Targeted Therapy Drug Development, Xinxiang, ChinaCollege of Pharmacy, Xinxiang Medical University, Xinxiang, ChinaHenan International Joint Laboratory of Cardiovascular Remodeling and Drug Intervention, Xinxiang, China.Xinxiang Key Laboratory of Vascular Remodeling Intervention and Molecular Targeted Therapy Drug Development, Xinxiang, ChinaCollege of Pharmacy, Xinxiang Medical University, Xinxiang, ChinaHenan International Joint Laboratory of Cardiovascular Remodeling and Drug Intervention, Xinxiang, China.Xinxiang Key Laboratory of Vascular Remodeling Intervention and Molecular Targeted Therapy Drug Development, Xinxiang, ChinaCollege of Pharmacy, Xinxiang Medical University, Xinxiang, ChinaDepartment of Ultrasonography, Henan Provincial People’s Hospital, People’s Hospital of Zhengzhou University, Zhengzhou, ChinaSchool of Basic Medical Sciences, Xinxiang Medical University, Xinxiang, ChinaHenan International Joint Laboratory of Cardiovascular Remodeling and Drug Intervention, Xinxiang, China.Xinxiang Key Laboratory of Vascular Remodeling Intervention and Molecular Targeted Therapy Drug Development, Xinxiang, ChinaCollege of Pharmacy, Xinxiang Medical University, Xinxiang, ChinaThe purpose of this study was to evaluate the protective effect of acidic fibroblast growth factor targeted mediated by novel nanoparticles–cationic lipid microbubbles complex (aFGF–NP + CPMBs) combined with ultrasound targeted microbubble destruction (UTMD)on doxorubicin–induced heart failure (HF)and its mechanism. Heart failure rats induced by intraperitoneal injection with doxorubicin (DOX) to achieve cummulative dose of 15mg/kg for continuous 6 weeks showed left ventricular dysfunction, seriously oxidative stress, cardiomyocyte apoptosis, and decrease of myocardial vascular density. In contrast, aFGF–NP + CPMBs combined with UTMD therapy (3ug/kg, caudal vein injection, twice a week, 6weeks)prominently ameliorated left ventricular dysfunction by increased ejection fraction (EF) and fractional shortening (FS), decreased brain natriuretic peptide (BNP); strengthened the ability of antioxidant stress confirmed by increasing the activity of SOD and reducing the production of MDA; exerted the effect of anti–cardiomyocyte apoptosis and promotion angiogenesis by inhibited Bax expression and increased Bcl–2 expression and platelet endothelial cell adhesion molecule (CD31) expression. Taken together, the research suggested that aFGF targeted mediated by novel nanoparticles–cationic lipid microbubbles complex combined with UTMD should be a promising targeted treatment for heart failure.https://www.frontiersin.org/articles/10.3389/fphar.2021.607785/fulldoxorubicinheart failureaFGF-NPanti-apoptoticangiogenesisUTMD |